Advanced Technology for Infectious Disease
Title: Using Modern Technology to Surveil, Monitor, and Diagnose Infectious Disease
Date: Monday, December 18
Time: 1 p.m. ET
Presenters: John Tamerius, PhD
Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.
Near-Real-Time: Surveil, Monitor, and Diagnose
The focus of this webinar is on utilizing modern technology to provide physicians, hospital administrators, medical and laboratory directors, and public health agencies with accurate and timely information about the status of infectious disease within a community, county or state.
This data management system can send — in near-real-time — the results of diagnostic tests for Influenza A&B, RSV, and Strep A to the CDC, state health departments, and healthcare organizations nationwide. In addition to transmitting actual test results, the system enables access to pre-programmed analytical tools, graphics, and regional mapping options that can be updated daily.
Join us as John Tamerius, PhD, walks us through these capabilities along with:
- Potential assistance in diagnosing infectious disease
- Near-real-time wireless transmission of results to public health agencies and organizations for surveillance and laboratory management
Learning Objectives
This webinar will help you:
- Identify technology that allows certain FDA-cleared, rapid-POC testing instruments to wirelessly transmit to public authorities
- Describe how labs can use the technology for quality control, training and resource management
- Analyze the impact of valid real-time data on patient care management, including the use of antivirals and antibiotics
- Discuss promising new applications of data to enhance disease forecasting and its benefits for various stakeholders
This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.
Presenter
John Tamerius, PhD
Senior Vice President of Strategic & External Affairs, Quidel Corp.
John Tamerius, PhD, cofounded Cytotech, Inc. and has led the development of more than 100 research and FDA-approved products for studying immune complexes, inflammation, and the complement system. Since Quidel Corporation acquired Cytotech in 1989, he has served as Head of Quality Assurance, Vice President of R&D, General Manager of Quidel’s northern California division, and Senior Vice President of Clinical & Regulatory Affairs.
As the VP of R&D, Dr. Tamerius oversaw the development of the Quidel™ QuickVue™ Influenza A+B lateral flow test and was responsible for the clinical trials and submissions that led to FDA clearances for the immunofluorescence-based Quidel™ Sofia™ analyzer and accompanying assays. His work was key to the validation of the Virena wireless communication system, which has been used to transmit and share nearly one million influenza test results with U.S. public health agencies.
Dr. Tamerius received his PhD in Microbiology and Immunology from the University of Washington (Seattle, WA) and performed research in tumor immunology at the Fred Hutchinson Cancer Research Center (Seattle, WA) before joining the Scripps Clinic and Research Foundation (San Diego, CA). As a Research Associate in the Scripps Department of Molecular Immunology, he continued his studies of inflammation and the complement system and became a National Arthritis Fellow.